 SCOTTSDALE, Ariz., Aug. 19, 2021 PRNewswire -- Electromedical Technologies, Inc. OTCQB: EMED the Company, a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, clarifies and corrects its previously published press release disclosing comparative results from the six months ended June 30, 2021 versus June 30, 2020. 